Amwell (NYSE: AMWL) reported Q4 EPS of ($0.99), $0.73 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $79.2 million versus the consensus estimate of $78.08 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.